NON-SMALL CELL LUNG CANCER STAGE IV
Clinical trials for NON-SMALL CELL LUNG CANCER STAGE IV explained in plain language.
Never miss a new study
Get alerted when new NON-SMALL CELL LUNG CANCER STAGE IV trials appear
Sign up with your email to follow new studies for NON-SMALL CELL LUNG CANCER STAGE IV, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New biosimilar aims to match keytruda for lung cancer treatment
Disease control OngoingThis study tests whether SB27, a biosimilar drug, works as well as Keytruda for people with advanced non-squamous non-small cell lung cancer. About 555 participants will receive either SB27 or Keytruda along with chemotherapy every 3 weeks. The main goal is to see if the tumor sh…
Matched conditions: NON-SMALL CELL LUNG CANCER STAGE IV
Phase: PHASE3 • Sponsor: Samsung Bioepis Co., Ltd. • Aim: Disease control
Last updated May 17, 2026 03:09 UTC
-
New hope for brain-spread cancers: dual immunotherapy injected into spinal fluid
Disease control OngoingThis early-phase study tests a new way to give immunotherapy drugs (nivolumab and ipilimumab) to people with lung cancer or melanoma that has spread to the lining of the brain and spinal cord (leptomeningeal metastases). The drugs are given both into the spinal fluid and through …
Matched conditions: NON-SMALL CELL LUNG CANCER STAGE IV
Phase: PHASE1 • Sponsor: University of Zurich • Aim: Disease control
Last updated May 14, 2026 12:03 UTC